Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours
about
Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.Therapeutic drug monitoring of targeted anticancer therapy.Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.
P2860
Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prediction of free imatinib co ...... strointestinal stromal tumours
@ast
Prediction of free imatinib co ...... strointestinal stromal tumours
@en
type
label
Prediction of free imatinib co ...... strointestinal stromal tumours
@ast
Prediction of free imatinib co ...... strointestinal stromal tumours
@en
prefLabel
Prediction of free imatinib co ...... strointestinal stromal tumours
@ast
Prediction of free imatinib co ...... strointestinal stromal tumours
@en
P2093
P2860
P50
P1476
Prediction of free imatinib co ...... strointestinal stromal tumours
@en
P2093
Amina Haouala
Michael Montemurro
Serge Leyvraz
P2860
P304
P356
10.1111/J.1365-2125.2012.04422.X
P407
P577
2013-04-01T00:00:00Z